T. Rowe Price discloses 6.9% Lazard (LAZ) stake in 13G/A
T. Rowe Price Associates, Inc. filed Amendment No. 1 to Schedule 13G reporting beneficial ownership of 7,759,451 shares of Lazard Inc (LAZ) common stock, representing 6.9% of the class as of the event date 09/30/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc. filed Amendment No. 1 to Schedule 13G reporting beneficial ownership of 7,759,451 shares of Lazard Inc (LAZ) common stock, representing 6.9% of the class as of the event date 09/30/2025.
The firm reports 7,730,026 shares with sole voting power and 7,759,451 shares with sole dispositive power, with 0 shared voting or dispositive power. The filing identifies the reporting person as an investment adviser and includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in LAZ does T. Rowe Price report?
What voting and dispositive powers are reported?
What is the event date for this Schedule 13G/A?
What type of filer is T. Rowe Price in this report?
Does the filing state an intent to influence control of Lazard Inc?
Is this an amendment to a prior 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.